PF-07868489 is a recombinant monoclonal antibody targeting GDF2/BMP-9. PF-07868489 can be used for the research of pulmonary arterial hypertension (PAH). Recommend Isotype Controls: Human IgG1 kappa, Isotype Control [1].
In Vitro, The BMP-9/GDF-2 protein is a potent angiogenesis inhibitor that selectively signals through AVRL1 in endothelial cells. Its signaling pathway requires the TGF-β co-receptor endoglin/ENG for efficient activation of SMAD1.
References:
[1]. Sitbon O, et al. Drugs targeting novel pathways in pulmonary arterial hypertension. Eur Respir J. 2025;66(2):2401830. Published 2025 Aug 8.
In Vitro, The BMP-9/GDF-2 protein is a potent angiogenesis inhibitor that selectively signals through AVRL1 in endothelial cells. Its signaling pathway requires the TGF-β co-receptor endoglin/ENG for efficient activation of SMAD1.
References:
[1]. Sitbon O, et al. Drugs targeting novel pathways in pulmonary arterial hypertension. Eur Respir J. 2025;66(2):2401830. Published 2025 Aug 8.